VanEck Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Buy |
54,137
+6,215
| +13% | +$2.11M | 0.01% | 454 |
|
|
2025
Q4 | $19.1M | Buy |
47,922
+6,789
| +17% | +$3M | 0.02% | 404 |
|
|
2025
Q3 | $18.8M | Sell |
41,133
-13,427
| -25% | -$5.47M | 0.02% | 375 |
|
|
2025
Q2 | $17.8M | Sell |
54,560
-9,584
| -15% | -$2.65M | 0.02% | 349 |
|
|
2025
Q1 | $17.3M | Sell |
64,144
-3,674
| -5% | -$944K | 0.02% | 345 |
|
|
2024
Q4 | $16M | Buy |
67,818
+10,419
| +18% | +$2.74M | 0.02% | 362 |
|
|
2024
Q3 | $16.9M | Sell |
57,399
-3,539
| -6% | -$921K | 0.02% | 342 |
|
|
2024
Q2 | $14.8M | Buy |
60,938
+3,015
| +5% | +$476K | 0.02% | 335 |
|
|
2024
Q1 | $8.66M | Sell |
57,923
-3,310
| -5% | -$552K | 0.01% | 437 |
|
|
2023
Q4 | $11.7M | Sell |
61,233
-9,853
| -14% | -$1.68M | 0.02% | 338 |
|
|
2023
Q3 | $12.6M | Sell |
71,086
-6,882
| -9% | -$1.31M | 0.03% | 310 |
|
|
2023
Q2 | $14.8M | Sell |
77,968
-3,313
| -4% | -$657K | 0.03% | 289 |
|
|
2023
Q1 | $16.3M | Sell |
81,281
-11,099
| -12% | -$2.33M | 0.04% | 271 |
|
|
2022
Q4 | $22M | Buy |
92,380
+22,484
| +32% | +$4.8M | 0.06% | 232 |
|
|
2022
Q3 | $14M | Sell |
69,896
-39,546
| -36% | -$7.54M | 0.04% | 265 |
|
|
2022
Q2 | $16M | Buy |
109,442
+9,436
| +9% | +$1.34M | 0.04% | 268 |
|
|
2022
Q1 | $16.3M | Buy |
100,006
+1,392
| +1% | +$212K | 0.03% | 286 |
|
|
2021
Q4 | $16.7M | Buy |
98,614
+5,913
| +6% | +$1.1M | 0.04% | 281 |
|
|
2021
Q3 | $17.5M | Sell |
92,701
-27,921
| -23% | -$5.24M | 0.04% | 263 |
|
|
2021
Q2 | $20.4M | Buy |
120,622
+20,368
| +20% | +$2.98M | 0.05% | 249 |
|
|
2021
Q1 | $14.2M | Sell |
100,254
-4,975
| -5% | -$749K | 0.04% | 285 |
|
|
2020
Q4 | $13.7M | Buy |
105,229
+18,790
| +22% | +$2.51M | 0.04% | 256 |
|
|
2020
Q3 | $12.6M | Sell |
86,439
-24,559
| -22% | -$3.49M | 0.04% | 233 |
|
|
2020
Q2 | $16.4M | Buy |
110,998
+23,994
| +28% | +$3.23M | 0.06% | 201 |
|
|
2020
Q1 | $9.47M | Sell |
87,004
-27,922
| -24% | -$3.22M | 0.05% | 228 |
|
|
2019
Q4 | $13.2M | Buy |
114,926
+3,885
| +3% | +$387K | 0.05% | 220 |
|
|
2019
Q3 | $8.93M | Buy |
111,041
+6,592
| +6% | +$522K | 0.04% | 230 |
|
|
2019
Q2 | $7.58M | Sell |
104,449
-20,824
| -17% | -$1.6M | 0.04% | 266 |
|
|
2019
Q1 | $11.7M | Buy |
125,273
+9,228
| +8% | +$772K | 0.06% | 201 |
|
|
2018
Q4 | $8.46M | Buy |
116,045
+4,622
| +4% | +$356K | 0.04% | 241 |
|
|
2018
Q3 | $9.75M | Buy |
111,423
+33,228
| +42% | +$3.34M | 0.05% | 244 |
|
|
2018
Q2 | $7.7M | Buy |
78,195
+10,950
| +16% | +$1.09M | 0.04% | 254 |
|
|
2018
Q1 | $8.01M | Sell |
67,245
-19,454
| -22% | -$2.51M | 0.04% | 248 |
|
|
2017
Q4 | $11M | Sell |
86,699
-68,486
| -44% | -$8.61M | 0.05% | 224 |
|
|
2017
Q3 | $18.2M | Buy |
155,185
+27,135
| +21% | +$2.32M | 0.09% | 174 |
|
|
2017
Q2 | $10.2M | Buy |
128,050
+25,273
| +25% | +$1.62M | 0.06% | 228 |
|
|
2017
Q1 | $5.27M | Sell |
102,777
-23,915
| -19% | -$1.11M | 0.02% | 290 |
|
|
2016
Q4 | $4.74M | Sell |
126,692
-2,179
| -2% | -$91.2K | 0.02% | 299 |
|
|
2016
Q3 | $8.73M | Sell |
128,871
-26,252
| -17% | -$1.85M | 0.04% | 224 |
|
|
2016
Q2 | $8.61M | Sell |
155,123
-16,756
| -10% | -$1.06M | 0.04% | 210 |
|
|
2016
Q1 | $10.8M | Sell |
171,879
-21,991
| -11% | -$1.46M | 0.07% | 167 |
|
|
2015
Q4 | $18.3M | Buy |
193,870
+43,021
| +29% | +$3.99M | 0.14% | 141 |
|
|
2015
Q3 | $12.1M | Sell |
150,849
-55,133
| -27% | -$6.13M | 0.09% | 166 |
|
|
2015
Q2 | $24.7M | Buy |
205,982
+18,554
| +10% | +$2.22M | 0.15% | 133 |
|
|
2015
Q1 | $19.6M | Buy |
+187,428
| New | +$19M | 0.11% | 148 |
|
Other funds holding ALNY
VPM
VCM
